Arysta LifeScience is a global provider of crop protection and life science products. From Anchorage to Auckland, our focus on providing product access in emerging markets ensures our products deliver when and where they`re most needed. Arysta LifeScience currently delivers through the following global regions: More than three-quarters of our entire organization is directly involved in bringing new products to market. From supply chain specialists, to development and registration teams, to sales and marketing representatives, we have more than 4,000 employees dedicated to helping growers succeed. With a focus on emerging countries and niche markets, Arysta LifeScience manages a portfolio of more than 200 active ingredients. The company operates in more than 100 countries worldwide.

Company details

Business Type:
Technology
Industry Type:
Agriculture - Crop Cultivation
Market Focus:
Globally (various continents)

Since its founding in 2001, Arysta LifeScience has been one of the fastest growing companies in the industry and is currently among the top 15 agrochemical companies in the world1. Over the past five years, Arysta LifeScience achieved positive sales growth exceeding the industry average.

This success has been made possible by strong, loyal partnerships with:

  • Our customers worldwide;
  • Research or science-based companies that provide us with the most advanced products for development; and
  • Reliable manufacturers of high-quality active ingredients.

In addition, we’ve proven our ability to bring products to market rapidly and effectively using a unique, solutions-oriented approach to portfolio management that focuses on the most profitable opportunities in our selected markets.

  • New product development and registration in select local markets;
  • Formulation and product packaging from externally sourced active ingredients; and
  • Marketing and distribution of both value-added and off-patent products to local wholesalers, retailers, cooperatives and, in some cases, directly to the farmer.

Our hybrid business model with a balanced, 50:50 mix of value-added and off-patent products, allows us to maintain a nimble, asset-light, low-capital investment approach, which is both downturn-resistant and highly scalable.

(1) Source: Phillips McDougall, May 2012Complementary animal health business

Arysta Animal Health (AAH), a business unit of Arysta LifeScience, gives the company a presence in two important niche markets:

  • Contract manufacturing and contract development for vet pharmaceutical companies
  • Honeybee health

With entities based in France, Spain and U.S., AAH offers products and services in more than 20 countries worldwide. Its range of branded and non-branded products for minor species, companion animals and livestock, also includes APIVAR®, a world leading proprietary anti-mite treatment for honey bees. Simultaneously promoting the veterinary and honeybee markets creates strong synergies to reduce time and cost-to-market while ensuring a high level of efficacy and innovation to serve customers.

Worldwide resources, distinctive customer- focused point of view

At Arysta LifeScience, we build our portfolio with an intense focus on the customer. We strive to work as partners with our customers by providing high-quality chemical solutions that meet the rapidly changing needs of growers raising a diverse range of crops. That means we offer products that address particular challenges in all parts of the world.

This partnership approach is made possible by our strategic focus on specific functions in the value chain: product development, registration, formulation and packaging, and marketing and distribution. As a result, we can respond to customer needs, expand our business without significant additional fixed costs and quickly capitalize on new dynamics and industry opportunities.